Kailera Therapeutics Revenue and Competitors

Waltham, USA

Location

N/A

Total Funding

Biotech

Industry

Employee Data

  • Kailera Therapeutics has 82 Employees.(i)

Kailera Therapeutics's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$81.4M37540%N/AN/A
#2
$16.9M10922%N/AN/A
#3
$156.1M120-70%$145MN/A
#4
$2.9M37-24%$150MN/A
#5
$1.3M170%$459.5MN/A
#6
$49.2M25415%$180.7MN/A
#7
$7M45-2%N/AN/A
#8
$256.3M8409%$168.5MN/A
#9
$10.1M655%N/AN/A
#10
$16.1M1049%N/AN/A
Add Company

What Is Kailera Therapeutics?

Kailera Therapeutics (Kailera) is developing a broad, advanced, and differentiated portfolio of clinical-stage injectable and oral therapies for the treatment of obesity and related conditions. Kailera’s most advanced program, KAI-9531 (being developed in China as HRS9531), is an injectable GLP-1/GIP receptor dual agonist that demonstrated positive results in Phase 2 trials in obesity and type 2 diabetes in China. The Company is also advancing a diversified pipeline leveraging several mechanisms and routes of delivery, including oral administration. Kailera’s mission is to develop next-generation weight management therapies that give people the power to transform their lives and elevate their overall health. The Company is based in Waltham, MA and San Diego, CA. For more information, visit www.kailera.com.

keywords:N/A

N/A

Total Funding

82

Number of Employees

N/A

Revenue (est)

N/A

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$11.9M82-6%N/A
#2
$12.9M832%$170M
#3
$12.9M8332%$7.7M
#4
$13.3M832%N/A
#5
$12.2M84-3%$29.9M